Iovance Biotherapeutics IOVA SEC Filings

NASDAQ IOVA
$8.09 +0.01 (+0.12%)
At close: Nov 11, 2026 · 4:00 PM EST
EDGAR Disclosures

SEC Filings

Source SEC EDGAR

Every SEC filing Iovance Biotherapeutics, Inc. (IOVA) has made, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

Form Type
# Form Type Form Group Accession Date Filing Index
18-KCurrent Report0001193125-26-450084Nov 5, 2026 5:00 PM
28-KCurrent Report0001104659-26-123030Nov 5, 2026 12:05 PM
310-QQuarterly & Annual Report0001193125-26-448809Nov 5, 2026 9:15 AM
48-KCurrent Report0001104659-26-120261Oct 29, 2026 9:00 PM
58-KCurrent Report0001104659-26-113763Oct 5, 2026 1:00 AM
64Insider Transaction0001104659-26-113342Oct 2, 2026 1:01 AM
73Insider Transaction0001104659-26-113341Oct 2, 2026 1:00 AM
88-KCurrent Report0001104659-26-111583Sep 29, 2026 7:05 AM
94Insider Transaction0001104659-26-106752Sep 10, 2026 9:01 PM
104Insider Transaction0001104659-26-106750Sep 10, 2026 9:00 PM
114Insider Transaction0001104659-26-106748Sep 10, 2026 9:00 PM
124Insider Transaction0001104659-26-105101Sep 3, 2026 9:02 PM
134Insider Transaction0001104659-26-105100Sep 3, 2026 9:02 PM
144Insider Transaction0001104659-26-105099Sep 3, 2026 9:00 PM
154Insider Transaction0001104659-26-095040Aug 12, 2026 9:30 PM
164Insider Transaction0001104659-26-093482Aug 10, 2026 9:30 PM
17SCHEDULE 13GBeneficial Ownership Report0000093751-26-000486Aug 7, 2026 1:56 PM
188-KCurrent Report0001104659-26-092145Aug 6, 2026 9:30 PM
1910-QQuarterly & Annual Report0001104659-26-091716Aug 6, 2026 1:15 PM
208-KCurrent Report0001104659-26-091619Aug 6, 2026 11:05 AM
21SCHEDULE 13GBeneficial Ownership Report0002012383-26-002600Jul 28, 2026 8:44 PM
228-KCurrent Report0001104659-26-080409Jul 2, 2026 9:01 PM
234Insider Transaction0001104659-26-075863Jun 18, 2026 9:17 PM
244Insider Transaction0001104659-26-075861Jun 18, 2026 9:16 PM
254Insider Transaction0001104659-26-075858Jun 18, 2026 9:16 PM
264Insider Transaction0001104659-26-075856Jun 18, 2026 9:15 PM
274Insider Transaction0001104659-26-075854Jun 18, 2026 9:15 PM
28S-8Prospectus0001104659-26-075832Jun 18, 2026 9:04 PM
29S-8Prospectus0001104659-26-075831Jun 18, 2026 9:03 PM
30S-3ASROthers0001104659-26-075778Jun 18, 2026 8:31 PM
318-KCurrent Report0001104659-26-072408Jun 10, 2026 9:01 PM
324Insider Transaction0001104659-26-071899Jun 9, 2026 9:03 PM
334Insider Transaction0001104659-26-071897Jun 9, 2026 9:01 PM
344Insider Transaction0001104659-26-071895Jun 9, 2026 9:00 PM
354Insider Transaction0001104659-26-071891Jun 9, 2026 9:00 PM
364Insider Transaction0001104659-26-070155Jun 3, 2026 9:02 PM
374Insider Transaction0001104659-26-070153Jun 3, 2026 9:01 PM
384Insider Transaction0001104659-26-070152Jun 3, 2026 9:00 PM
394Insider Transaction0001104659-26-070149Jun 3, 2026 9:00 PM
404Insider Transaction0001104659-26-060356May 13, 2026 9:00 PM
41SCHEDULE 13GBeneficial Ownership Report0000093751-26-000249May 12, 2026 3:17 PM
428-KCurrent Report0001104659-26-056782May 7, 2026 1:18 PM
4310-QQuarterly & Annual Report0001104659-26-056778May 7, 2026 1:16 PM
44ARSOthers0001104659-26-054229May 1, 2026 9:00 PM
45DEFA14AOthers0001104659-26-050467Apr 28, 2026 9:05 PM
46DEF 14AOthers0001104659-26-050458Apr 28, 2026 9:01 PM
47PRE 14AOthers0001104659-26-044958Apr 17, 2026 9:01 PM
48SCHEDULE 13GBeneficial Ownership Report0000102909-26-001540Mar 27, 2026 1:52 PM
498-KCurrent Report0001104659-26-032774Mar 20, 2026 9:00 PM
504Insider Transaction0001104659-26-026475Mar 11, 2026 9:25 PM
...

Iovance Biotherapeutics, Inc. SEC Filings API

Pull Iovance Biotherapeutics, Inc.'s SEC filing index, with links to every filing and exhibit, into your own tools with the Business Quant SEC Filings API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/secfilings?ticker=IOVA&formtype=10-K,10-Q&api_key=YOUR_API_KEY